Share-based Payment Arrangement, Expense in USD of Nuo Therapeutics, Inc. from Q2 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Nuo Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2013 to Q3 2025.
  • Nuo Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $19,915.000, a 4.79% decline year-over-year.
  • Nuo Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $92,033.000, a 184% increase year-over-year.
  • Nuo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $56,652.000, a 161% increase from 2023.
  • Nuo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $21,746.000, a 138% increase from 2022.
  • Nuo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9,145.000.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Nuo Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $92,033 $19,915 -$1,001 -4.8% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $93,034 $23,201 +$20,120 +6.5% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $72,914 $19,343 +$16,262 +5.3% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 $56,652 $29,574 +$24,195 +4.5% 01 Oct 2024 31 Dec 2024 10-K 01 Apr 2025
Q3 2024 $32,457 $20,916 +$9,389 +81.5% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 $23,068 $3,081 +$661 +27.3% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025
Q1 2024 $22,407 $3,081 +$661 +27.3% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 $21,746 $5,379 +$11,612 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2025
Q3 2023 $10,134 $11,527 +$10,091 +7% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $43.00 $2,420 -$5,092 -67.8% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $5,135 $2,420 -$4,010 -62.4% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $9,145 -$6,233 -$6,233 01 Oct 2022 31 Dec 2022 10-K 19 Apr 2024
Q3 2022 $15,378 $1,436 +$1,436 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023
Q2 2022 $13,942 $7,512 +$7,512 01 Apr 2022 30 Jun 2022 10-Q/A 10 Aug 2022
Q1 2022 $6,430 $6,430 +$6,430 01 Jan 2022 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $0 $0 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 $0 $0 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022
Q2 2021 $0 $0 01 Apr 2021 30 Jun 2021 10-Q/A 10 Aug 2022
Q1 2021 $0 $0 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-K 15 Apr 2022
Q2 2020 $0 01 Apr 2020 30 Jun 2020 10-K 15 Apr 2022
Q1 2020 $0 01 Jan 2020 31 Mar 2020 10-K 15 Apr 2022
Q3 2014 $390,889 +$240,826 +1.6% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2014
Q2 2014 $370,589 +$151,957 +69.5% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2014
Q3 2013 $150,063 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 $218,632 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014

Nuo Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $56,652 +$34,906 +1.6% 01 Jan 2024 31 Dec 2024 10-K 01 Apr 2025
2023 $21,746 +$12,601 +1.4% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2025
2022 $9,145 +$9,145 01 Jan 2022 31 Dec 2022 10-K 19 Apr 2024
2021 $0 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.